Back to Careers

CEO. Dr. Hanadie Yousef participates in AFAR’s webinar on AI + Longevity Drug Discovery

Back to Careers

CEO Dr. Hanadie Yousef gives a talk on Juvena’s AI-enabled protein drug discovery and development platform and lead therapeutic candidates for muscle regeneration and enhancing fat metabolism at the Longevity Summit Dublin

Back to Careers

CEO Dr. Hanadie Yousef represents Juvena on 2 panels at BIO San Diego to discuss navigating the frontiers of First-in-Class therapeutics, and how healthspan promoting therapeutics are entering the biopharma mainstream.

Back to Careers

CEO Dr. Hanadie Yousef represents Juvena on 2 panels at BIO San Diego to discuss navigating the frontiers of First-in-Class therapeutics, and how healthspan promoting therapeutics are entering the biopharma mainstream.

Back to Careers

Juvena is selected by the World Economic Forum to join its 2024 global cohort of Technology Pioneers, awarded to the 100 most innovative tech startups applying new breakthroughs in AI to solve some of the biggest challenges of our time.

Back to Careers

Dr. Jeremy O’Connell, Director of translation Dr. Priya Handa, and Scientist Dr. Ritwik Datta attend and present our latest results at ENDO 2024, highlighting how  JUV-112 Offers a Distinctive Approach to Weight Loss and Metabolic Health

Back to Careers

Dr. Jeremy O’Connell, Director of translation Dr. Priya Handa, and Scientist Dr. Ritwik Datta attend and present our latest results at ENDO 2024, highlighting how  JUV-112 Offers a Distinctive Approach to Weight Loss and Metabolic Health

Back to Careers

Juvena’s SVP of Translation, Dr. Mo Tabrizi participates in the Seattle Myotonic Dystrophy Regional Summit, where Juvena gave an industry presentation.

Back to Careers

Juvena’s CEO Dr. Hanadie Yousef participates in the LA Myotonic Dystrophy Regional Summit, where Juvena gave an industry presentation.

Back to Careers

Juvena’s Director of Discovery & Platform, Dr. Thach Mai presents “Mapping the therapeutic potential of secreted proteins through integrating AI and quantitative multi-omics technology” at the Element Biosciences Roadshow